Shanghai, China, May 9, 2018 – Broda Technologies Co., Ltd. today announced it had been granted a new US Patent 9,937,254 on April 10, 2018 for a patent titled “Water-Soluble Supramolecular Complexes”.
The patent extends the coverage of Company’s supramolecular smart drug delivery technology to anhydrous form and its application in pharmaceutical, cosmetic and personal care products. “The granting of a new US patent for the Water-Soluble Supramolecular Complexes extends and broadens the coverage of the supramolecular smart drug delivery technology for water insoluble drugs in anhydrous form. Supramolecular smart drug delivery technology has wide potential applications with enhanced efficacy, patient compliance, and safety compared with existing pharmaceutical and cosmetic products.” stated Broda Technologies’ President Dr. Shao Lu.
About Broda Technologies
Broda Technologies Co. Ltd. is a technology company focus on supramolecular smart drug delivery technology and the development of related products. The Company’s proprietary supramolecular smart drug delivery system is capable of dissolving water insoluble or sparely soluble drugs with sustained release for enhanced efficacy, safety and patient’s compliance. For more information, please visit www.brodatech.com.
Contact
Broda Technologies Co., Ltd.
Shao Lu, Ph.D.
Tel: +86 21 2022 5388
E-mail: info@brodatech.com
Find out how our breakthrough smart supramolecular drug delivery plateform technology can help you maximizing potential of your development drug and related consumer care products.
Email: